ovarian cancer
Conditions
Interventions
Probe development group:None
Non developing group:None
Sponsors
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with ovarian epithelial malignancies, who have extensive implantation and metastasis on enhanced CT/MRI of the pelvis and abdomen, and are diagnosed with FIGO stage II-IV ovarian cancer; 2. Patients who underwent 68Ga-EB-FAPI probe PET/CT examination within 10 days and whose radionuclide imaging showed positive results; 3. Patients without surgical contraindications and expected to undergo R0 resection in cytoreductive surgery; 4. Patients with complete medical records, aged between 18 and 70 years; 5. Patients who can follow the research protocol and undergo regular follow-up; 6. Patients have given consent and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Severe abnormalities in liver and kidney functions; 2. Those who cannot lie flat for half an hour; 3. Those who cannot tolerate all clinical examinations; 4. Those with tumor cell ablation surgery who cannot undergo R0 resection during the operation; 5. Those with contraindications for surgery and who cannot tolerate it; 6. Those with other malignant tumors; 7. Other situations judged by the researchers as not suitable for inclusion in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Two-year progression-free survival rate; | — |
Countries
China
Contacts
Public ContactJinwei Miao; Xinyi Zhang
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Outcome results
None listed